RECIST response and variation of circulating tumour cells in phase 1 trials: A prospective multicentric study.
Massard C, Borget I, Farace F, Aspeslagh S, Le Deley MC, Le Tourneau C, Bidard FC, Pierga JY, Dieras V, Hofman P, Spano JP, Ferte C, Lacroix L, Soria JC.
Massard C, et al. Among authors: aspeslagh s.
Eur J Cancer. 2017 Sep;83:185-193. doi: 10.1016/j.ejca.2017.05.016. Epub 2017 Jul 22.
Eur J Cancer. 2017.
PMID: 28743036